De novo ulcerative colitis and Takotsubo cardiomyopathy following sleeve gastrectomy

  1. Bernardo Andres Acevedo-Mendez 1 , 2,
  2. Yuting Ye 1 , 2,
  3. John Nihad Makaryus 2 , 3 and
  4. Benjamin Hirsh 2 , 3
  1. 1 Department of Medicine, North Shore University Hospital, Manhasset, New York, USA
  2. 2 Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA
  3. 3 Department of Cardiology, North Shore University Hospital, Manhasset, New York, USA
  1. Correspondence to Dr Bernardo Andres Acevedo-Mendez; bacevedome@northwell.edu

Publication history

Accepted:31 Oct 2022
First published:18 Nov 2022
Online issue publication:18 Nov 2022

Case reports

Case reports are not necessarily evidence-based in the same way that the other content on BMJ Best Practice is. They should not be relied on to guide clinical practice. Please check the date of publication.

Abstract

The increasing prevalence of severe obesity is a major public health concern. Bariatric surgery is an important treatment option for severe obesity due to its long-term sustained result. Multiple studies have shown that patients have an increased risk of developing inflammatory bowel disease following bariatric surgery. Takotsubo syndrome usually presents as acute left ventricular systolic dysfunction without corresponding obstructive coronary artery disease after an acute stress episode. We describe a unique case of a patient who developed de novo ulcerative colitis and takotsubo cardiomyopathy shortly after sleeve gastrectomy. The patient made a successful recovery due to prompt recognition and appropriate treatment.

Background

The obesity epidemic may be the most pressing long-term public health issue we face. Based on data collected for the National Health and Nutrition Examination Survey from 2017 to 2018, the prevalence of obesity in the USA was 42.4%.1 For patients with severe obesity (defined as body mass index greater than 40 kg/m2) with comorbidities such as type 2 diabetes mellitus or hepatic steatosis, bariatric surgery is an effective treatment option.2 3 Over the last decade, sleeve gastrectomy has become a popular surgical option given faster recovery time and lower risk of complications.4 Multiple studies have shown patients have an increased risk of developing inflammatory bowel disease (IBD) after bariatric surgeries, more commonly Crohn’s disease rather than ulcerative colitis.5–7 IBD has also been described as a stressor for Takotsubo syndrome (TTS).8 TTS usually presents as an acute left ventricular systolic dysfunction without corresponding obstructive coronary artery disease after a precipitating event. It is thought to be due to a rise in circulating catecholamine levels in asetting of acute physiologic and/or psychological stress.9 10

We report a distinctive case of a postmenopausal woman who developed IBD and takotsubo cardiomyopathy following bariatric surgery. We also performed a literature review on these topics.

Case presentation

A woman in her 60s with a medical history of class 3 obesity, hepatic steatosis, hyperlipidaemia and diet-controlled diabetes presented to the emergency department (ED) with nausea, vomiting and diarrhoea. She had laparoscopic sleeve gastrectomy and hiatal hernia repair three months prior and was doing well until 2 weeks prior to admission. She developed generalised weakness from her numerous non-bloody watery bowel movements.She was advised to proceed to the ED for further evaluation. Her home medications included omeprazole, lisinopril, ondansetron and multivitamin.

Investigations

Initial laboratory results on presentation were notable for electrolyte abnormalities and anaemia of chronic disease (table 1).

Table 1

Initial laboratories results

Test Result
White cell count 7.85×109/L
Haemoglobin level 10.0 g/dL
Mean cell volume 88.4 fl
Platelet count 534×109 /L
Serum sodium 136 mmol/L
Serum potassium 2.9 mmol/L
Serum chloride 95 mmol/L
Serum carbon dioxide 23 mmol/L
Serum anion gap 18 mmol/L
Serum blood urea nitrogen 11 mg/dL
Serum creatinine 0.51 mg/dL
Serum glucose 138 mg/dL
Total serum calcium 9.2 mg/dL
Serum albumin 3.1 g/dL
Serum ferritin 1239 ng/mL
Serum iron total 31 ug/dL
Total iron binding capacity 136 ug/dL
Stool wright stain Positive
Stool testing for clostridium difficileglutamate dehydrogenaze and toxin A and Benzyme immunoassay Negative
Stool gastrointestinal(GI) PCR Not detected
Stool culture No enteric pathogens isolated
Stool calprotectin 3742 ug/g
COVID-19 PCR Not detected

Differential diagnosis

The most important differential diagnoses in such a case are acute coronary syndrome including non-ST-segment elevation myocardial infarction, coronary artery vasospasm and myocarditis. Acute coronary syndrome was excluded as coronary angiography showed non-obstructive coronary artery disease. Coronary artery spasm was not appreciated on angiography. Given the lack of elevation of cardiac biomarkers, myocarditis was unlikely. This patient’s presentation of T wave inversion and QT interval prolongation on ECG, elevated pro-BNP, normal range of cardiac enzymes, presence of mid to distal SPECT myocardial perfusion abnormalities and wall motion abnormalities in the context of a preceding stressful event, with an unremarkable coronary angiogram, fulfils the International Takotsubo Diagnostic Criteria from the Heart Failure Association.11

Treatment

Outcome and follow-up

The patient’s symptoms improved, and she was discharged on aspirin, metoprolol succinate and atorvastatin. She saw a gastroenterologist who tapered her steroids. She felt improved and self-discontinued metoprolol and aspirin. She was also given age-appropriate vaccinations in preparation for vedolizumab infusion. She began exercising 2 hours a day. She followed up with a cardiologist and had a TTE with a normal left ventricular ejection fraction of 65% with no regional wall motion abnormalities.

Discussion

Multiple case series and studies have shown the occurrence of de novo IBD following bariatric surgery, although the mechanism remains unclear. Ungaro et al identified fifteen patients with a new diagnosis of IBD following bariatric surgery.6 Most cases were women who had Roux-en-Y gastric bypass, 10 cases developedCrohn’s disease, 4 cases ulcerative colitis and 1 case an unclassified IBD. Their group also conducted a matched case–control study using medical and pharmacy claims from 2008 to 2012 in a US national database. Their study included 8980 cases and 43 059 controls. A history of bariatric surgery was associated with an increased risk of new-onset IBD (OR 1.93, 95% CI 1.34 to 2.79).6 Similar findings were appreciated by Braga Neto et al who reviewed records from Mayo Clinic and Washington University School of Medicine from 1 January 1996 to 31 December 2016 and identified 44 patients who developed de novo IBD after bariatric surgery.5

Notably, this same group from the Mayo Clinic also has a prospectively maintained database on all bariatric surgery cases. From 1 January 1996 to 31 December 2016, 3709 patients underwent bariatric surgery at Mayo Clinic, and the incidence of IBD in this patient population was 26.7 per 100 000 person-years. The age-adjusted standardised incidence ratio (SIR, observed divided by expected) ranged from 3.56 in the 40–49 year age group to 4.73 in the 30–39 years age group. The expected number was derived using age-adjusted and sex-adjusted incidence rates of Crohn’s disease in Olmstead County, Minnesota (1970–2010).5

Patients who have had recent bariatric surgery may experience non-specific symptoms including nausea, vomiting, diarrhoea, abdominal pain or weight loss, similar in presentation as IBD. Thus, a strong clinical suspicion of IBD is important as delays in diagnosis can have adverse outcomes. An IBD flare can cause emotional and physiological stress on the body, which may lead to TTS in susceptible patients. Mirijello et al described multiple cases of concurrent IBD and TTS and noted several similarities between these diseases such as higher prevalence among females, recurrent disease course, association with endothelial dysfunction and affective disorders.8

Most cases of TTS have a preceding emotional or physical stress which triggers a rise in the circulating catecholamine levels, with subsequent circulating catecholamine-mediated microvascular dysfunction and myocardial stunning.9 In the USA, TTS incidence was approximated between 15 and 30 cases per 1 00 000 patients per year.11 This syndrome affects women more often than men. The International Takotsubo Registry had 1750 patients with takotsubo cardiomyopathy, 89.8% of them were women, predominantly postmenopausal.12

Prompt differentiation of TTS from acute coronary syndrome, acute viral or autoimmune myocarditis is essential. TTS can be identified by changes in ST segments on ECG that extend beyond the perfusion territory of a single coronary artery, and by lack of significant elevations in biomarkers of myocardial injury.9 10 Furthermore, TTS can be distinguished from ACS by a high pro-BNP to troponin ratio, reflecting the relatively minor myocyte necrosis but significant ventricular dysfunction.9

This patient’s non-classical LV apical ballooning can hypothetically be related to variation in myocardial beta-1 and beta-2 adrenergic receptors density between apical and basal segments.8 9 As with this patient, most patients with TTS will recover left ventricular systolic function within weeks, while others can have complications such as heart failure and arrhythmias.9 10

To our knowledge, this is the first case of TTS following new-onset ulcerative colitis after sleeve gastrectomy. After bariatric surgery, TTS and de novo IBD are both rare, underdiagnosed and more common in women.5 11 As discussed earlier, TTS disproportionately affects postmenopausal women, and there is evidence suggesting oestrogen deficiency may play a key role in the pathogenesis of TTS. Due to decreased levels of oestrogen, postmenopausal women have an increased sympathetic drive and endothelial dysfunction.13 14 Ueyama et al established an elegant animal model for TTS using ovariectomised rats, and their experiments showed oestrogen supplement improves the stress-induced cardiovascular dysfunction by indirect action on the nervous system and by direct action on the heart.15 Fu et al used an injection of high dose epinephrine to induce TTS in adult rats and in human-induced pluripotent stem cells-derived cardiomyocytes, and they showed that activation of G protein-coupled oestrogen receptor which executes the rapid effects of oestrogen prevented an increase in left ventricular internal diameter at end-systole and a decrease both in ejection fraction and cardiomyocyte shortening amplitude in epinephrine-induced TTS.16 Excess adiposity is associated with increased oestrogen, and weight loss is associated with decreased oestrogen levels. Rock et al showed that postmenopausal women who lost ≥5% of body weight at 6 months had significantly lower estrone, estradiol and bioavailable estradiol concentration than women who did not lose at least 5% of body weight.17 The patient in our case lost approximately 20% of her body weight in the 3 months following her laparoscopic sleeve gastrectomy. We hypothesise that the acutely reduced level of oestrogen due to loss of adipose tissues combined with the physiological stress of IBD contributed to TTS in our patient. Due to the limited number of case reports, we cannot prove such cause or effect, and further research is needed to further understand the pathophysiology of TTS and guide future therapies.

Learning points

  • Recognise new-onset inflammatory bowel disease (IBD) when evaluating a patient who presents with diarrhoea or other non-specific gastrointestinal symptoms after bariatric surgery.

  • Recognise Takotsubo cardiomyopathy in postmenopausal women in the setting of a recent physical stressor such as IBD and bariatric surgery.

  • More research is needed on women’s health as both postbariatric surgery IBD, and Taotsubo Syndrome occurred in the female gender, and both carry a risk of relapsing.

Ethics statements

Patient consent for publication

Acknowledgments

We sincerely thank Northwell Health, the Medicine Service Line, the Department of Medicine, and the Department of Cardiology for their support.

Footnotes

  • Twitter @DrAcevedoMendez

  • Contributors BAA-M conducted the initial proposal of the case report and acquisition of the data. BAA-M, YY, JNM and BH contributed in equal parts to the interpretation of the data, performing the literature review, planning, design and writing of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

References

Use of this content is subject to our disclaimer